Boston-based Dana-Farber Cancer Institute’s $1.68 billion cancer hospital, currently under construction, will be named the Lavine Bekenstein Cancer Hospital at Dana-Farber.
Dana-Farber President and CEO Benjamin Ebert, MD, PhD, shared the hospital’s official name June 25 on LinkedIn.
The hospital was named in honor of the Josh and Anita Bekenstein and the Jonathan and Jeannie Lavine families, who gave Dana-Farber the largest single gift in the institute’s history in February.
The 300-bed cancer hospital will operate as a joint venture between Dana-Farber Cancer Institute, Boston-based Beth Israel Deaconess Medical Center and Harvard Medical Faculty Physicians.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
